An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use
Authors
Keywords
Survival analysis, Competing risks, Restricted mean survival time, HIV, Injection drug use, Antiretroviral therapy
Journal
BMC Medical Research Methodology
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-09
DOI
10.1186/s12874-018-0484-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A longitudinal, HIV care continuum
- (2016) Catherine R. Lesko et al. AIDS
- Brief Report
- (2016) Elizabeth T. Rogawski et al. EPIDEMIOLOGY
- All your data are always missing: incorporating bias due to measurement error into the potential outcomes framework
- (2015) Jessie K Edwards et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000–2013
- (2015) Richard M. Novak et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Illustration of a Measure to Combine Viral Suppression and Viral Rebound in Studies of HIV Therapy
- (2015) Jessie K. Edwards et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework: Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy
- (2014) S. R. Cole et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Disparities in the Quality of HIV Care When Using US Department of Health and Human Services Indicators
- (2014) K. N. Althoff et al. CLINICAL INFECTIOUS DISEASES
- Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
- (2013) Patrick Royston et al. BMC Medical Research Methodology
- Decomposition of number of life years lost according to causes of death
- (2013) P. K. Andersen STATISTICS IN MEDICINE
- Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail
- (2012) Qi Gong et al. PHARMACEUTICAL STATISTICS
- Splines for Trend Analysis and Continuous Confounder Control
- (2011) Chanelle J. Howe et al. EPIDEMIOLOGY
- Invited Commentary: Positivity in Practice
- (2010) D. Westreich et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Concerning the Consistency Assumption in Causal Inference
- (2010) Tyler J. VanderWeele EPIDEMIOLOGY
- Estimating Absolute Risks in the Presence of Nonadherence
- (2010) Sengwee Toh et al. EPIDEMIOLOGY
- On the Consistency Rule in Causal Inference
- (2010) Judea Pearl EPIDEMIOLOGY
- On causal inference in the presence of interference
- (2010) Eric J Tchetgen Tchetgen et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Diagnosing and responding to violations in the positivity assumption
- (2010) Maya L Petersen et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Invited Commentary: Causal Diagrams and Measurement Bias
- (2009) M. A. Hernan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Competing Risk Regression Models for Epidemiologic Data
- (2009) B. Lau et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
- Pseudo-observations in survival analysis
- (2009) Per Kragh Andersen et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- The Consistency Statement in Causal Inference
- (2008) Stephen R. Cole et al. EPIDEMIOLOGY
- Toward Causal Inference With Interference
- (2008) Michael G Hudgens et al. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started